Wed.Nov 06, 2024

article thumbnail

STAT+: AstraZeneca says China has detained a senior executive

STAT

The executive in charge of AstraZeneca operations in China is under detention by Chinese authorities who are investigating employees there, the company said. The disclosure comes after AstraZeneca last week acknowledged that Leon Wang, an executive vice president who also oversees international operations for the drugmaker, was being investigated along with a “small number” of employees.

363
363
article thumbnail

A diabetes drug, twice rejected, stumbles again — but its developer persists

PharmaVoice

After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 diabetes therapy.

Diabetes 148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Pharma’s ethically questionable sites essentially sell drugs directly to consumers

STAT

Want to self-prescribe a prescription drug? No problem! Some of the largest pharmaceutical companies in the U.S. are piloting websites that essentially sell their drugs directly to consumers. This unprecedented move launches a new dystopic era: pharmaceutical companies as health care provider, no pesky physician middlemen needed. It’s what the pharmaceutical industry has always wanted: They have long viewed physicians as inconvenient barriers between the company and their customers.

article thumbnail

An RNAi renaissance is creating a new generation of startups

BioPharma Dive

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Psychedelics decriminalization rejected by Massachusetts voters

STAT

Massachusetts voters on Tuesday rejected Question 4, the ballot measure that proposed decriminalizing the use of psychedelic substances for people older than 21 and allowing people to grow the hallucinogens at home. The AP projected the result in the early morning hours of Wednesday. The initiative proposed to decriminalize the use of five psychedelic compounds, most notably  psilocybin , or so-called magic mushrooms, which can dramatically affect a person’s perceptions and thinking.

article thumbnail

XRHealth buys NeuroReality in health XR marriage

pharmaphorum

Two players in medical extended reality (XR) – XRHealth and NeuroReality – have come together in a quest to build the biggest company in the sector.Boston, US-based XRHealth is leading the deal, acquiring NeuroReality of the Netherlands for an undisclosed sum, combining their products and expertise in the use of XR and virtual reality software for healthcare applications.

115
115

More Trending

article thumbnail

While the Orphan Battles Wages, Jazz Takes a Loss

FDA Law Blog: Biosimilars

By Sara W. Koblitz — The fight between Jazz, Avadel, and FDA over narcolepsy drug sodium oxybate has been a long and arduous one. Starting in 2022 with a patent certification requirement, both Jazz and Avadel have sued FDA over this drug, with Jazz most recently bringing suit challenging FDA’s decision that Avadel’s Lumryz (sodium oxybate) is clinically superior to Jazz’s Xywav (sodium oxybate) in 2023.

Labelling 109
article thumbnail

STAT+: Pharmalittle: We’re reading about compounded Wegovy, pharmacies suing GoodRx, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. Regardless of elections, we generally see the proverbial glass as half full. For those of you who worry the sky is falling, we will pass along something learned on Wall Street: “Sell sky.” After all, we have made it this far, so we are determined to hang on for another couple of days.

article thumbnail

First-of-a-kind EU approval granted for eosinophilic esophagitis medicine

European Pharmaceutical Review

Dupixent (dupilumab) has been approved by the European Medicines Agency (EMA) as the first treatment for young children with eosinophilic esophagitis in the EU. This authorisation is based on Phase III data which found that 68 percent of children aged one to 11 years given Dupixent (dupilumab) achieved histological disease remission at 16 weeks. This result was maintained for up to one year.

105
105
article thumbnail

Opinion: How your genetics could determine your politics

STAT

No matter who wins the 2024 presidential race, one thing is clear: Political anxiety and division will remain high for the foreseeable future. So just before Election Day, I spoke with Kevin Smith, a professor of political science at the University of Nebraska who studies the intersection of political attitudes, biology, and evolution.  In 2019, he and colleagues published a study that found almost 40% of Americans reported experiencing stress over politics, 11.5% thought their physical hea

250
250
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Rubicon Research secures SEBI approval for IPO

Express Pharma

Rubicon Research has received approval from the Securities and Exchange Board of India (SEBI) to proceed with an Initial Public Offering (IPO). The IPO will include a fresh issue of equity shares worth Rs 500 crore and an Offer For Sale (OFS) of shares valued at Rs 585 crore, sold by General Atlantic Singapore RR Pte, Rubicon’s promoter, as outlined in the Draft Red Herring Prospectus (DRHP) filed in July 2024.

105
105
article thumbnail

AstraZeneca falls on reports of Chinese probe

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning, major news this morning, so let’s get straight to it.

article thumbnail

OmniActive acquires ENovate Biolife to expand global health ingredient offerings

Express Pharma

OmniActive Health Technologies (OmniActive) has announced its acquisition of ENovate Biolife (ENovate), a developer of clinically researched botanical ingredients. The transaction, financed through internal accruals, is expected to strengthen OmniActive’s position in delivering scientifically validated health ingredients to consumers worldwide. OmniActive, backed by TA Associates, has advanced encapsulation technologies to enhance ingredient solubility, stability, and bioavailability.

105
105
article thumbnail

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

Pharmaceutical Technology

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts by the US Federal Reserve in September 2024.

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharma funding drops 64% in October 2024, but shows slight increase from last year

Express Pharma

Funding in the pharma and healthcare space decreased by 64.36 per cent in October 2024, amounting to $72 million, compared to $202 million raised in September 2024. Despite this decline, the October 2024 figure marked a slight increase of 5.26 per cent from the $68.4 million raised in October 2023. In terms of stagewise funding, early-stage and seed-stage rounds together accounted for approximately half of the total funding in October.

103
103
article thumbnail

Wegovy romps ahead after key rival sees slowdown

pharmaphorum

Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago.

102
102
article thumbnail

Researchers identify protein IL-35 as potential diabetes treatment

Express Pharma

A recent study led by the Institute of Advanced Study in Science and Technology (IASST) in Guwahati has identified a protein, IL-35, that may offer a novel approach to diabetes treatment. The research highlights IL-35’s capacity to protect the immune system by reducing specific immune cells that release inflammatory chemicals, which are linked to pancreatic cell infiltration, a significant factor in type 1 and autoimmune diabetes mellitus.

Diabetes 101
article thumbnail

Company Profile: HCG

pharmaphorum

HCG’s drive to transform is motivated by industry-leading perspective on the emerging trend of “impact”, and recognition that understanding that the impact of medical communications efforts is more critical than ever.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Pharma sector sees drop in deal value amid october 2024 activity: GlobalData report

Express Pharma

In October 2024, the healthcare industry reported 102 deals valued at $8.9 billion, marking a 69 per cent decline in deal value compared to October 2023. According to GlobalData, this deal activity also fell short of the average over the past 12 months (October 2023 to September 2024), which recorded an average of 97 deals worth $17.5 billion. Three significant acquisitions contributed to 59 per cent of the total deal value in October 2024.

98
article thumbnail

Alligator pancreatic cancer drug 'nearly doubles' survival

pharmaphorum

New results with Alligator's CD40 agonist mitazalimab show it nearly doubled survival in pancreatic cancer, ahead of phase 3 trial next year.

104
104
article thumbnail

Streamlining eCOA: From complex setup to simplified solutions

Outsourcing Pharma

As clinical trials evolve, electronic Clinical Outcome Assessments (eCOA) remain central to data quality but often lag in adoption due to complex setup and deployment challenges.

80
article thumbnail

How to Develop a Risk Management Plan for Generic Drugs

Drug Patent Watch

Developing a Risk Management Plan (RMP) for generic drugs is a crucial step in ensuring the safety and efficacy of these medications. An RMP provides detailed information on a medicine’s safety profile, measures to prevent or minimize risks, and plans for ongoing safety monitoring and evaluation.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

MHRA grants approval for bladder cancer drug erdafitinib

Pharma Times

New therapy targets specific genetic alterations, promises extended survival

110
110
article thumbnail

Who You Gonna Email? Digital Health Question Busters!

FDA Law Blog: Biosimilars

By Jennifer D. Newberger — Though digital health is not new, it can still often be difficult to determine with precision the regulatory requirements applicable to a particular software product. Sometimes this is because FDA has not opined on a specific set of facts, but more often it is because FDA seems to take different approaches to the same technology offered by different companies.

70
article thumbnail

Arcellx to present positive data on multiple myeloma treatments

Pharma Times

Phase 1 and 2 studies show promising results for anito-cel therapy

112
112
article thumbnail

Discussing climate impact helps engage patients in medicines optimisation

The Pharmacist

Pharmacists should talk to patients about benefits other than cost savings to help tackle medicines wastage, a pharmacy lead told a Public Policy Projects (PPP) conference in London yesterday. In particular, talking about the impact of medicines on climate change could help to engage patients in medicines optimisation, he suggested. Speaking at the PPP Integrated […] The post Discussing climate impact helps engage patients in medicines optimisation appeared first on The Pharmacist.

69
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Moderna said to shuffle sales leadership; Vertex records first Casgevy sale

BioPharma Dive

Stephen Hoge will now oversee vaccine sales at Moderna, per a Bloomberg report. Elsewhere, Intra-Cellular unveiled an ambitious sales target and Syndax inked a lucrative royalty deal.

article thumbnail

The GP Awards shortlist: Chiswick PCN Pharmacy Team

The Pharmacist

We caught up with the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards ceremony to be held on 6 December at the Novotel London West. The Chiswick Primary Care Network Pharmacy Team has established itself as a valuable part of the local healthcare landscape, demonstrating the value of pharmacy […] The post The GP Awards shortlist: Chiswick PCN Pharmacy Team appeared first on The Pharmacist.

61
article thumbnail

The Future of Temperature-Controlled Technology

Pharmaceutical Commerce

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Delphine Perridy, chief commercial officer, Envirotainer, forecasts the future of the pharma cold chain regarding technological advancements and changes in market dynamics.

59
article thumbnail

SolasCure partners with US Army for better wound care technology

Pharmafile

SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal of neurotic tissue to encourage healing – and healing solutions for chronic wounds has announced a partnership with the US Army’s Institute of Surgical Research (USAISR). The partnership has aims to improve the current solutions […] The post SolasCure partners with US Army for better wound care technology appeared first on Pharmafile.

59
article thumbnail

Acadia sells speedy drug review voucher for $150M

BioPharma Dive

The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be pushing values higher, according to one analyst.

57